@article{907cdd3214ad4deca1b17af708e74f50,
title = "Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)",
keywords = "ESTEEM, apremilast, clinical trial, phosphodiesterase 4 inhibitor, psoriasis, treatment",
author = "Kim Papp and Kristian Reich and Leonardi, {Craig L.} and Leon Kircik and Sergio Chimenti and Langley, {Richard G.B.} and Hu, {Chia Chi} and Stevens, {Randall M.} and Day, {Robert M.} and Gordon, {Kenneth B.} and Korman, {Neil J.} and Griffiths, {Christopher E.M.}",
note = "Publisher Copyright: {\textcopyright} 2015 American Academy of Dermatology, Inc.",
year = "2015",
month = jul,
day = "1",
doi = "10.1016/j.jaad.2015.03.049",
language = "English",
volume = "73",
pages = "37--49",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",
}